Market Tracker

10/30 11:07am ET
7.35
Real-Time Quote
 -0.11 / -1.47%
Today’s Change
7.20
Today|||52-Week Range
14.32
-17.88%
Year-to-Date

Today’s Trading

Previous close7.46
Today’s open7.44
Day’s range7.31 - 7.45
Volume70,060
Average volume (3 months)110,293
Market cap$373.7M
Dividend yield--
Data as of 10:52am ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)+5.26%
Earnings growth (this year)+19.44%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,366.53%
P/E ratioNM
Price/Sales98.02
Price/Book9.59

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+0.27+1.44%
PACBPacific Biosciences ...+0.39+6.36%
RNAProsensa Holding NV-0.33-2.98%
ANIPANI Pharmaceuticals ...+0.14+0.43%
Data as of 11:07am ET, 10/30/2014

Financials

Next reporting dateFebruary 10, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$3.5M
Annual profit (last year)-$14.1M
Net profit margin-396.82%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Anat Cohen-Dayag
Chief Financial Officer
Ari Krashin
Corporate headquarters
Tel Aviv, --

Forecasts